CERo Therapeutics Holdings, Inc.
CERO
$0.04
$0.008.70%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -775.79% | -14.86% | -121.23% | -122.02% | 153.11% |
| Total Depreciation and Amortization | -2.99% | -8.24% | -8.73% | -6.49% | -0.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.95% | 42.17% | 145.47% | 121.32% | -2,593.39% |
| Change in Net Operating Assets | -92.49% | -42.78% | -163.11% | 92.22% | 1,051.96% |
| Cash from Operations | -147.15% | -16.19% | -30.70% | 12.49% | -60.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -348.30% |
| Issuance of Common Stock | 116.48% | -- | -- | -0.77% | 35,189.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 166.24% | 160.20% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -647.28% | 908.13% | -- | -- | -117.40% |
| Cash from Financing | 131.79% | -42.83% | 5.06% | -11.68% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -577.40% | -379.99% | -100.92% | -9.68% | 94.47% |